AKT1 and intrahepatic cholangiocarcinoma: Although Pten mutations were not found in our computational analysis of ICC, loss of Pten recapitulates the effects of PI3KCA mutations (which is mutated in 5.4% of patients in our cohort, Fig. 1C; ref. 40), resulting in the accumulation of PIP3 and AKT activation.